AAMC

NEW YORK (GenomeWeb News) – A bill in the US House of Representatives that includes funding for the National Institutes of Health has stirred concerns among some of NIH's advocates because it includes several proposals that they say would hinder the NIH in its mission.

The institutes will use mostly standard grant channels to speedily spend $10.4 billion on research and equipment, while adhering to the spending deadline and oversight rules.

The stimulus package aimed at stemming the recession gives NIH a "bold" funding boost for 2009 and 2010.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.